On Dec 07, major Wall Street analysts update their ratings for $UiPath (PATH.US)$, with price targets ranging from $15 to $18.
Morgan Stanley analyst Sanjit Singh maintains with a hold rating, and adjusts the target price from $15 to $16.
J.P. Morgan analyst Mark Murphy maintains with a buy rating, and adjusts the target price from $17 to $18.
BofA Securities analyst Bradley Sills maintains with a hold rating, and maintains the target price at $18.
BMO Capital analyst Keith Bachman maintains with a hold rating, and adjusts the target price from $15 to $16.
Oppenheimer analyst Brian Schwartz maintains with a hold rating.
Furthermore, according to the comprehensive report, the opinions of $UiPath (PATH.US)$'s main analysts recently are as follows:
The firm assesses that UiPath's third quarter resonated with the patterns observed in the second quarter, displaying a robust performance that exceeded modest expectations. This illustrates augmented execution and efficiency. However, despite an attractive valuation, the firm retains a cautious stance while monitoring for indications of sustained growth in net-new ARR.
With software becoming increasingly favored, valuation levels have now aligned with historical averages. Moreover, there's potential for further upside, as estimates have not yet adjusted upward and base valuations are projected to extend out to 2026.
UiPath exhibited favourable performance this quarter, marked by slight improvements across several crucial indicators including net new annual recurring revenue. The introduction of new agent tools presents further opportunities, albeit in a competitive landscape. Despite the attractive valuation of UiPath's stock, the complexity within the company's fundamental operations remains a hurdle for adopting a more optimistic outlook.
Here are the latest investment ratings and price targets for $UiPath (PATH.US)$ from 8 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美東時間12月7日，多家華爾街大行更新了$UiPath (PATH.US)$的評級，目標價介於15美元至18美元。
摩根士丹利分析師Sanjit Singh維持持有評級，並將目標價從15美元上調至16美元。
摩根大通分析師Mark Murphy維持買入評級，並將目標價從17美元上調至18美元。
美銀證券分析師Bradley Sills維持持有評級，維持目標價18美元。
BMO資本市場分析師Keith Bachman維持持有評級，並將目標價從15美元上調至16美元。
奧本海默控股分析師Brian Schwartz維持持有評級。
此外，綜合報道，$UiPath (PATH.US)$近期主要分析師觀點如下：
該公司評估認爲，UiPath第三季度的表現與第二季度觀察到的模式相符，展現出強勁的表現，超出溫和的預期。這顯示了執行力和效率的提升。然而，儘管估值吸引人，該公司仍保持謹慎態度，同時關注淨新年度經常性收入持續增長的因子。
隨着軟件越來越受到青睞，估值水平現在已與歷史平均水平對齊。此外，由於預計尚未向上調整，且基礎估值預計將延續到2026年，還有進一步上漲的潛力。
UiPath本季度表現良好，多個關鍵因子的輕微改善，包括淨新年度經常性收入。新代理工具的引入提供了進一步機會，儘管在競爭激烈的市場中。儘管UiPath股票的估值吸引，但公司基本運營的複雜性仍然是採用更樂觀展望的障礙。
以下爲今日8位分析師對$UiPath (PATH.US)$的最新投資評級及目標價：
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
